Medpace Total Assets from 2010 to 2024

MEDP Stock

USD 337.75 4.07 1.19%

Medpace Holdings Total Assets yearly trend continues to be relatively stable with very little volatility. Total Assets are likely to drop to about 1.3 B. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2014-12-31

Previous Quarter

1.9 B

Current Value

2.1 B

Quarterly Volatility

304.5 M

Yuan Drop

Covid

Check Medpace Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medpace Holdings' main balance sheet or income statement drivers, such as Depreciation And Amortization of 34.3 M, Interest Expense of 463.6 K or Selling General Administrative of 91.4 M, as well as many indicators such as Price To Sales Ratio of 3.21, Dividend Yield of 0.0 or PTB Ratio of 17.69. Medpace financial statements analysis is a perfect complement when working with Medpace Holdings Valuation or Volatility modules.

Check out the analysis of Medpace Holdings Correlation against competitors.

To learn how to invest in Medpace Stock, please use our How to Invest in Medpace Holdings guide.

Latest Medpace Holdings' Total Assets Growth Pattern

Below is the plot of the Total Assets of Medpace Holdings over the last few years. Total assets refers to the total amount of Medpace Holdings assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Medpace Holdings books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Medpace Holdings' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Medpace Holdings' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 1.66 B

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Medpace Total Assets Regression Statistics

	Arithmetic Mean	1,193,956,703
	Geometric Mean	1,174,447,244
	Coefficient Of Variation	19.60
	Mean Deviation	190,685,337
	Median	1,096,912,000
	Standard Deviation	234,017,708
	Sample Variance	54764.3T
	Range	709.2M
	R-Value	0.67
	Mean Square Error	32704.1T
	R-Squared	0.45
	Significance	0.01
	Slope	34,925,792
	Total Sum of Squares	766700T

Medpace Total Assets History

	2024	1.3 B
	2023	1.7 B
	2022	1.4 B
	2021	1.7 B
	2020	1.4 B
	2019	1.1 B
	2018	967.9 M

Other Fundumenentals of Medpace Holdings

Intangibles To Total Assets

Medpace Holdings Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Good Will	Short Term Investments	Total Liab	Deferred Long Term Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.54	0.42	0.81	-0.69	-0.02	0.74	-0.5	0.81	-0.42	-0.45	0.68	0.11	-0.38	0.95	0.76	-0.56	-0.22	0.81	-0.53	0.7	-0.03	-0.23	-0.47
Total Stockholder Equity	0.54		0.92	0.4	-0.91	0.53	0.56	-0.72	0.41	-0.22	-0.58	-0.24	0.48	-0.68	0.75	0.54	-0.7	0.49	0.52	-0.72	0.59	0.48	0.39	0.0
Net Tangible Assets	0.42	0.92		0.28	-0.86	0.49	0.61	-0.75	0.42	0.06	-0.59	-0.32	0.52	-0.73	0.67	0.31	-0.73	0.66	0.53	-0.78	0.59	0.45	0.39	0.17
Current Deferred Revenue	0.81	0.4	0.28		-0.7	-0.47	0.85	-0.71	0.89	-0.77	-0.57	0.58	0.01	-0.6	0.76	0.91	-0.77	-0.35	0.84	-0.67	0.84	-0.5	-0.64	-0.86
Net Debt	-0.69	-0.91	-0.86	-0.7		-0.16	-0.82	0.91	-0.72	0.43	0.71	0.0	-0.38	0.85	-0.86	-0.75	0.91	-0.32	-0.77	0.9	-0.86	-0.11	-0.01	0.31
Retained Earnings	-0.02	0.53	0.49	-0.47	-0.16		-0.3	0.15	-0.4	0.46	0.14	-0.48	0.4	0.16	0.13	-0.23	0.19	0.51	-0.25	0.1	-0.31	0.96	0.96	0.74
Accounts Payable	0.74	0.56	0.61	0.85	-0.82	-0.3		-0.88	0.95	-0.4	-0.7	0.38	0.28	-0.81	0.82	0.71	-0.93	0.05	0.95	-0.89	0.95	-0.33	-0.44	-0.53
Long Term Debt	-0.5	-0.72	-0.75	-0.71	0.91	0.15	-0.88		-0.77	0.44	0.78	0.05	-0.3	0.97	-0.68	-0.66	0.98	-0.35	-0.78	0.98	-0.93	0.21	0.26	0.43
Net Receivables	0.81	0.41	0.42	0.89	-0.72	-0.4	0.95	-0.77		-0.46	-0.62	0.58	0.12	-0.67	0.82	0.76	-0.81	-0.11	0.96	-0.8	0.92	-0.45	-0.56	-0.61
Good Will	-0.42	-0.22	0.06	-0.77	0.43	0.46	-0.4	0.44	-0.46		0.31	-0.3	0.14	0.38	-0.36	-0.85	0.47	0.46	-0.39	0.32	-0.51	0.47	0.55	0.88
Short Term Investments	-0.45	-0.58	-0.59	-0.57	0.71	0.14	-0.7	0.78	-0.62	0.31		-0.02	-0.26	0.77	-0.57	-0.52	0.74	-0.26	-0.63	0.82	-0.78	0.16	0.2	0.33
Total Liab	0.68	-0.24	-0.32	0.58	0.0	-0.48	0.38	0.05	0.58	-0.3	-0.02		-0.29	0.15	0.45	0.41	-0.05	-0.68	0.49	0.01	0.29	-0.45	-0.6	-0.55
Deferred Long Term Liab	0.11	0.48	0.52	0.01	-0.38	0.4	0.28	-0.3	0.12	0.14	-0.26	-0.29		-0.25	0.25	0.11	-0.3	0.31	0.33	-0.34	0.18	0.25	0.31	0.23
Short Long Term Debt	-0.38	-0.68	-0.73	-0.6	0.85	0.16	-0.81	0.97	-0.67	0.38	0.77	0.15	-0.25		-0.57	-0.55	0.95	-0.46	-0.68	0.95	-0.89	0.17	0.22	0.36
Total Current Assets	0.95	0.75	0.67	0.76	-0.86	0.13	0.82	-0.68	0.82	-0.36	-0.57	0.45	0.25	-0.57		0.76	-0.72	0.03	0.85	-0.71	0.79	0.1	-0.07	-0.34
Short Term Debt	0.76	0.54	0.31	0.91	-0.75	-0.23	0.71	-0.66	0.76	-0.85	-0.52	0.41	0.11	-0.55	0.76		-0.71	-0.3	0.73	-0.61	0.76	-0.28	-0.4	-0.75
Intangible Assets	-0.56	-0.7	-0.73	-0.77	0.91	0.19	-0.93	0.98	-0.81	0.47	0.74	-0.05	-0.3	0.95	-0.72	-0.71		-0.23	-0.82	0.96	-0.94	0.23	0.3	0.48
Common Stock	-0.22	0.49	0.66	-0.35	-0.32	0.51	0.05	-0.35	-0.11	0.46	-0.26	-0.68	0.31	-0.46	0.03	-0.3	-0.23		-0.03	-0.39	0.15	0.5	0.55	0.59
Property Plant Equipment	0.81	0.52	0.53	0.84	-0.77	-0.25	0.95	-0.78	0.96	-0.39	-0.63	0.49	0.33	-0.68	0.85	0.73	-0.82	-0.03		-0.81	0.9	-0.32	-0.43	-0.51
Long Term Debt Total	-0.53	-0.72	-0.78	-0.67	0.9	0.1	-0.89	0.98	-0.8	0.32	0.82	0.01	-0.34	0.95	-0.71	-0.61	0.96	-0.39	-0.81		-0.93	0.17	0.22	0.34
Capital Surpluse	0.7	0.59	0.59	0.84	-0.86	-0.31	0.95	-0.93	0.92	-0.51	-0.78	0.29	0.18	-0.89	0.79	0.76	-0.94	0.15	0.9	-0.93		-0.33	-0.44	-0.56
Net Invested Capital	-0.03	0.48	0.45	-0.5	-0.11	0.96	-0.33	0.21	-0.45	0.47	0.16	-0.45	0.25	0.17	0.1	-0.28	0.23	0.5	-0.32	0.17	-0.33		0.97	0.75
Net Working Capital	-0.23	0.39	0.39	-0.64	-0.01	0.96	-0.44	0.26	-0.56	0.55	0.2	-0.6	0.31	0.22	-0.07	-0.4	0.3	0.55	-0.43	0.22	-0.44	0.97		0.84
Capital Stock	-0.47	0.0	0.17	-0.86	0.31	0.74	-0.53	0.43	-0.61	0.88	0.33	-0.55	0.23	0.36	-0.34	-0.75	0.48	0.59	-0.51	0.34	-0.56	0.75	0.84

Click cells to compare fundamentals

About Medpace Holdings Financial Statements

Medpace Holdings shareholders use historical fundamental indicators, such as Total Assets, to determine how well the company is positioned to perform in the future. Although Medpace Holdings investors may analyze each financial statement separately, they are all interrelated. The changes in Medpace Holdings' assets and liabilities, for example, are also reflected in the revenues and expenses on on Medpace Holdings' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Total Assets	1.7 B	1.3 B
Intangibles To Total Assets	0.42	0.73

Pair Trading with Medpace Holdings

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medpace Holdings position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medpace Holdings will appreciate offsetting losses from the drop in the long position's value.

Moving against Medpace Stock

0.43	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr
0.38	AQB	AquaBounty Technologies	Pair Corr
0.37	EWTX	Edgewise Therapeutics	Pair Corr
0.37	FLGC	Flora Growth Corp	Pair Corr
0.36	VRDN	Viridian Therapeutics	Pair Corr

The ability to find closely correlated positions to Medpace Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medpace Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medpace Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medpace Holdings to buy it.

The correlation of Medpace Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medpace Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medpace Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Medpace Holdings can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Medpace Stock Analysis

When running Medpace Holdings' price analysis, check to measure Medpace Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medpace Holdings is operating at the current time. Most of Medpace Holdings' value examination focuses on studying past and present price action to predict the probability of Medpace Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medpace Holdings' price. Additionally, you may evaluate how the addition of Medpace Holdings to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC